Preparing high-growth private companies for a listing.
We work with revenue-generating and high-potential private enterprises to assess listing fit, choose the right route to market — direct IPO, de-SPAC or restructuring — and build the readiness and equity story that public-market investors expect.
Who this is for
Founders, boards and shareholders of private companies weighing a listing in the next 12–36 months.
High-growth enterprises
Revenue-generating, or pre-revenue with strong technology or commercial potential and a credible path to scale.
Targeting Nasdaq
Seeking a listing on the Nasdaq Global Select, Global or Capital Market tier, and ready to meet US reporting obligations.
Cross-border issuers
Companies in India, Hong Kong and Greater China, Southeast Asia and beyond who need an independent read on how US investors will see them — with on-the-ground support in Asia and California.
Three paths to a capital. One question: which fits your company?
NASDAQ Public Companies (Secondary Market & Restructuring)
Small-to-mid cap companies listed on NASDAQ (Facing delisting risks, forced share buyout pressure, or market cap maintenance challenges. Seeking follow-on financing, PIPE (Private Investment in Public Equity), debt-to-equity swaps, or secondary share offerings.)
HKEX GEM Public Companies (M&A & Equity Divestment)
Listed enterprises on the HKEX GEM board (Seeking strategic or financial buyers for partial or majority equity stake transfers. Looking for cross-border M&A deals or corporate growth financing).
Pre-IPO Pipeline Candidates (US Capital Markets)
High-growth private enterprises (revenue-generating or strong tech/commercial potential). Seeking a NASDAQ Main Board listing via direct IPO, Reverse Merger (De-SPAC), or Clean Non-GO corporate restructuring.
Nasdaq tightened its initial listing standards through 2025–26, including higher minimum offering proceeds and public float, and additional requirements for companies principally operating in China. Route choice now starts with a hard look at eligibility.
What we do
Independent, research-led advisory that sits alongside your counsel, auditors and underwriters.
Listing-fit assessment
Your financials and structure tested against current Nasdaq initial listing standards for each tier.
Route recommendation
IPO, de-SPAC or restructuring compared on timeline, cost, dilution and post-listing liquidity.
Readiness gap review
Audit status, governance, board independence and reporting capability — what must change before filing.
Equity story and positioning
A macro- and sector-grounded investment narrative built for US institutional investors.
How the process works
Submit
Complete the form below. It takes about 10 minutes.
Initial screen
Every submission is reviewed, and you hear back within 07 business days either way.
Confidential call
A working session with management.
Assessment and proposal
A written listing-fit and route assessment, with a scoped engagement proposal.
Submit your company for review
Share what you can today. High-level figures are enough at this stage.
Prefer email? Write to pallavisehgal@punjab.capital
Questions founders ask
Can you guarantee a Nasdaq listing?
No. Listing approval rests with Nasdaq and registration with the SEC. Our job is to tell you early and honestly whether, how and when a listing is realistic.
Do you underwrite or raise capital?
No — Punjab Capital is not an underwriter or broker-dealer. We work alongside the banks, counsel and auditors.
Is my information kept confidential?
Yes. Submissions are seen only by the Punjab Capital team, and detailed financials are exchanged only under a mutual NDA.
Who is not a fit?
Companies looking for a shell listing without a real business, or for a listing within weeks rather than months.